Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

By F. A. van de Laar, P. Lucassen, R. Akkermans, E. H. van de Lisdonk, G. Rutten, C. van Weel. Diabetes Care, 2005

637 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/f9984a1c756caad7a8881de6ec2e548e566974bf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. C. Apovian

Citations in the corpus

• Pharmacological management of obesity: an endocrine Society clinical practice guideline. (2015, background): “-Glucosidase inhibitors such as acarbose and miglitol may be weight neutral or lead to a small change in weight (152, 153).”